Dehydrocorydalin
Dehydrocorydaline exerts anti-metastatic potential via suppression of MMPs and Bcl-2 signaling in NSCLC cells. Dehydrocorydaline stimulates p38 MAPK activation, which can enhance heterodimerization of MyoD and E proteins, thus resulting in MyoD activation and myoblast differentiation. Dehydrocorydaline shows antiplatelet effects, it inhibits thrombin-induced platelet aggregation in a low dose (IC50= 34.914 ug/mL) . Dehydrocorydaline has anti-inflammatory and antinociceptive effects. Dehydrocorydaline inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.
Product Specifications
CAS Number
30045-16-0
Product Name Alternative
13-Methylpalmatine
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 25 mg/mL (68.23 mM)
Smiles
CC1=C2C=CC (=C (C2=C[N+]3=C1C4=CC (=C (C=C4CC3) OC) OC) OC) OC
Molecular Formula
C22H24NO4+
Molecular Weight
366.43
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Calmodulin (Phosphodiesterase 3'-5'-Cyclic Nucleotide Activator) (Biotin)
Calmodulin (Phosphodiesterase 3'-5'-Cyclic Nucleotide Activator) (Biotin)